Gutkowska Jolanta, Aliou Yessoufou, Lavoie Julie L, Gaab Katie, Jankowski Marek, Broderick Tom L
Cardiovascular Biochemistry Laboratory, Centre de Recherché du Centre Hospitalier de l 'Université de Montréal, Montréal, Québec, Canada; Département de Medecine, Université de Montréal, Montreal, Quebec, Canada.
Cardiovascular Biochemistry Laboratory, Centre de Recherché du Centre Hospitalier de l 'Université de Montréal, Montréal, Québec, Canada; Département de Pharmacologie, Université de Montréal, Montreal, Quebec, Canada.
Pathophysiology. 2016 Jun;23(2):111-21. doi: 10.1016/j.pathophys.2016.03.003. Epub 2016 Mar 17.
In this study, we assessed the effects of oxytocin (OT) on mean arterial blood pressure (MAP), heart rate (HR), and locomotor activity (LA) in male spontaneous hypertensive rats (SHR) and Sprague-Dawley (SDR) controls using telemetry. OT was given by intravenous injections of 0.1, 0.2 or 0.4mg/kg to assess short term acute effects or by daily subcutaneous injections of 0.5 or 1.0mg/kg for 5 days. Compared to the saline infusion, (i) intravenous OT, regardless of concentration, increased MAP in SHR and SDR, (ii) HR increased, but was periodically lower in both strains with 0.2 or 0.4mg/kg, and (iii) no effects of OT on LA were observed. Subcutaneous injections demonstrated that (i) 1.0mg/kg for 5days lowered diurnal MAP and HR in SDR and SHR, persisting for 6 days, (ii) 1.0mg/kg decreased nocturnal HR in SDR, (iii) 0.5 and 1.0mg/kg decreased MAP with minor effects on HR in the SHR, and lastly (iv) OT decreased LA mainly during the diurnal cycle in both strains. Our main results show that OT induces significant beneficial effects on cardiovascular function over several diurnal and nocturnal cycles in the SHR, with the most prominent effect being a robust decrease in MAP.
在本研究中,我们使用遥测技术评估了催产素(OT)对雄性自发性高血压大鼠(SHR)和Sprague-Dawley(SDR)对照大鼠的平均动脉血压(MAP)、心率(HR)和运动活动(LA)的影响。通过静脉注射0.1、0.2或0.4mg/kg的OT来评估短期急性效应,或通过每日皮下注射0.5或1.0mg/kg,持续5天。与输注生理盐水相比,(i)静脉注射OT,无论浓度如何,均使SHR和SDR的MAP升高,(ii)HR升高,但在两种品系中,0.2或0.4mg/kg时HR会周期性降低,(iii)未观察到OT对LA有影响。皮下注射表明,(i)连续5天注射1.0mg/kg可降低SDR和SHR的日间MAP和HR,并持续6天,(ii)1.0mg/kg可降低SDR的夜间HR,(iii)0.5和1.0mg/kg可降低SHR的MAP,对HR影响较小,最后(iv)OT主要在两个品系的日间周期降低LA。我们的主要结果表明,OT在多个昼夜周期对SHR的心血管功能产生显著有益影响,最显著的作用是MAP显著降低。